Advertisement

Sensitivity of Childhood Acute Lymphoblastic Leukemia Cells to Prednisolone and Dexamethasone Assessed by the MTT Assay

  • G. J. L. Kaspers
  • R. Pieters
  • C. H. Van Zantwijk
  • F. C. De Waal
  • E. R. Van Wering
  • A. J. P. Veerman
Conference paper
Part of the Haematology and Blood Transfusion / Hämatologie und Bluttransfusion book series (HAEMATOLOGY, volume 34)

Abstract

Glucocorticoids like predniso(lo)ne and dexamethasone are well known for their antileukemic activity, especially in acute lymphoblastic leukemia (ALL). Several groups have investigated the sensitivity of malignant lymphoid cells to glucocorticoids (GCs) and possibilities to predict this sensitivity. Special attention was given to the correlation between GC receptor numbers and sensitivity to these drugs, with conflicting results [1–4]. The clinical response to an initial prednisone (PRD) monotherapy was shown to have prognostic value in childhood ALL, firstly in small patient-groups [3, 5], later in the large BFM-ALL 83 study [6]. Differences in GC sensitivity might be important to consider in the design of an optimal treatment for each individual. In vitro sensitivity testing is an attractive method to investigate these differences.

Keywords

Acute Myeloid Leukemia Acute Lymphoblastic Leukemia Glucocorticoid Receptor Disodium Phosphate Antileukemic Activity 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Lippman ME, Konior G, Leventhal BG (1978) Clinical implications of glucocorticoid receptors in human leukemia. Cancer Res 38: 4251–4256PubMedGoogle Scholar
  2. 2.
    Homo F, Duval D, Harousseau JL et al. (1980) Heterogeneity of the in vitro responses to glucocorticoids in acute leukemia. Cancer Res 40: 2601–2608PubMedGoogle Scholar
  3. 3.
    Pui C-H, Dahl GV, Rivera G et al. (1984) The relationship of blast cell glucocorticoid receptor levels to response to single-agent steroid trial and remission response in children with acute lymphoblastic leukemia. Leuk Res 8: 579–585PubMedCrossRefGoogle Scholar
  4. 4.
    Nanni P, Nicoletti G, Prodi G et al. (1982) Glucocorticoid receptor and in vitro sensitivity to steroid hormones in human lymphoproliferative diseases and myeloid leukemia. Cancer 49: 623–632PubMedCrossRefGoogle Scholar
  5. 5.
    Mastrangelo R, Riccardi R, Corbo S et al. (1984) Prediction of clinical response to glucocorticoids in children with acute lymphoblastic leukemia. Eur Paediatr Haematol Oncol 1: 33–36CrossRefGoogle Scholar
  6. 6.
    Riehm H, Reiter A, Schrappe M et al. (1986) Die Corticosteroidabhängige Dezimierung der Leukämiezellzahl im Blut als Prognosefaktor bei der akuten lymphoblastischen Leukämie im Kindesalter (Therapiestudie ALL-BFM 83). Klin Pädiatr 199: 151–160CrossRefGoogle Scholar
  7. 7.
    Lerner LJ, Bianchi A, Turkheimer AR et al. (1964) Anti-inflammatory steroids: potency, duration and modification of activities. Ann N Y Acad Sci 116: 1071–1077PubMedCrossRefGoogle Scholar
  8. 8.
    Nakai T (1961) Influences of small doses of various corticosteroids on the incidence of chemically induced subcutaneous sarcomas in mice. Cancer Res 21: 221–227PubMedGoogle Scholar
  9. 9.
    Jones B, Shuster JJ, Holland J (1984) Lower incidence of meningeal leukemia when dexamethasone is substituted for prednisone in the treatment of acute lymphoblastic leukemia — a late follow-up. Proc Am Soc Clin Oncol 3: 191 (abstract)Google Scholar
  10. 10.
    Veerman AJP, Hählen K, Kamps WA et al. (1990). Dutch Childhood Leukemia Study Group: early results of study ALL VI. In: Büchner T, Schellong G, Hiddemann W, Ritter J (eds) Acute leukemias II. Springer, Berlin, Heidelberg New York, pp 473–477CrossRefGoogle Scholar
  11. 11.
    Sargent JM, Taylor CG (1989) Appraisal of the MIT assay as a rapid test of chemosensitivity in acute myeloid leukemia. Br J Cancer 60: 206–210PubMedCrossRefGoogle Scholar
  12. 12.
    Hongo T, Fujii Y, Igarashi Y (1990) An in vitro chemosensitivity test for the screening of anti-cancer drugs in childhood leukemia. Cancer 65: 1263–1272PubMedCrossRefGoogle Scholar
  13. 13.
    Pieters R, Loonen AH, Huismans DR et al. (1990) In vitro drug sensitivity of cells from children with leukemia using the MTTassay with improved culture conditions. Blood 76: 2327–2336PubMedGoogle Scholar
  14. 14.
    Pieters R, Kaspers GJL, Van Wering ER et al. (1991) In vitro drug resistance in childhood acute lymphoblastic leukemia in relation to age and immunophenotype. This volumeGoogle Scholar
  15. 15.
    Pieters R, Huismans DR, Loonen AH et al (1991). Relations of cellulas drug resistance to long-term clinical outcome in childhood acute lymphoblastic leukemia. Lancet 338: 399–403PubMedCrossRefGoogle Scholar
  16. 16.
    Van Dongen JJM, Adriaansen HJ, Hooijkaas H (1987) Immunologic marker analysis of cells in the various hematopoietic differentiation stages and their malignant counterparts. In: Ruiter DJ et al. (eds) Application of monoclonal antibodies in tumor pathology. Nijhoff, Dordrecht, pp 87–116CrossRefGoogle Scholar
  17. 17.
    Kaspers GJL, Pieters R, Van Zantwijk CH et al. (1991) In vitro drug sensitivity of normal peripheral blood lymphocytes and childhood leukaemic cells from bone marrow and peripheral blood. Bn J Canar 64: 469–474CrossRefGoogle Scholar
  18. 18.
    Cline MJ, Rosenbaum E (1968) Prediction of in vivo cytotoxicity of chemotherapeutic agents by their in vitro effect on leukocytes from patients with acute leukemia. Cancer Res 28: 2516–2521PubMedGoogle Scholar
  19. 19.
    Cantrill HC, Waltman SR, Palmberg PF et al. (1975) In vitro determination of relative corticosteroid potency. J Clin Endocrinol Metab 40: 1073–1077PubMedCrossRefGoogle Scholar
  20. 20.
    Berliner DL, Ruhmann AG (1967) Influence of steroids on fibroblasts. I. An in vitro fibroblast assay for corticosteroids. J Invest Dermatol 49: 117–122PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1992

Authors and Affiliations

  • G. J. L. Kaspers
    • 1
  • R. Pieters
    • 1
  • C. H. Van Zantwijk
    • 1
  • F. C. De Waal
    • 1
    • 2
  • E. R. Van Wering
    • 2
  • A. J. P. Veerman
    • 1
    • 2
  1. 1.Department of PediatricsFree University HospitalAmsterdamThe Netherlands
  2. 2.Dutch Childhood Leukemia Study GroupThe HagueThe Netherlands

Personalised recommendations